Paper26317460
DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension.
Licht JD. Cell, 2015. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension. Papers, record 26317460. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26317460
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimetabolites, Antineoplastic | Major topic |
| Azacitidine | Major topic |
| Colorectal Neoplasms | Major topic |
| DNA Methylation | Major topic |
| Interferon Type I | Major topic |
| Melanoma | Major topic |
| Animals | |
| Female | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U54 CA193419 | NCI NIH HHS | United States | U54CA193419 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment on | 26317465 | DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. | https://conductscience.org/library/papers/26317465 | PubMed |
| Comment on | 26317466 | Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. | https://conductscience.org/library/papers/26317466 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41582215 | Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41582215 | PubMed |
| 41190324 | A novel mechanism by which c-MYC is aberrantly activated by epigenetic silencing of its antisense lncRNA in colon cancer. | Front Genet | 2025 | https://conductscience.org/library/papers/41190324 | PubMed |
| 40352490 | Recent Advances in Therapeutic Peptides: Innovations and Applications in Treating Infections and Diseases. | ACS Omega | 2025 | https://conductscience.org/library/papers/40352490 | PubMed |
| 38554170 | Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement. | Mol Divers | 2024 | https://conductscience.org/library/papers/38554170 | PubMed |
| 37543704 | Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways. | Commun Biol | 2023 | https://conductscience.org/library/papers/37543704 | PubMed |
| 36660694 | Value of genomics- and radiomics-based machine learning models in the identification of breast cancer molecular subtypes: a systematic review and meta-analysis. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/36660694 | PubMed |
| 36350516 | The Role of DNA Methylation and DNA Methyltransferases in Cancer. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/36350516 | PubMed |
| 36324900 | Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36324900 | PubMed |
| 36213536 | Carbohydrate-based drugs launched during 2000-2021. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/36213536 | PubMed |
| 35836879 | A systematic pan-cancer analysis identifies RIOK3 as an immunological and prognostic biomarker. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/35836879 | PubMed |
| 35715584 | Activation of lnc-ALVE1-AS1 inhibited ALV-J replication through triggering the TLR3 pathway in chicken macrophage like cell line. | Vet Res Commun | 2023 | https://conductscience.org/library/papers/35715584 | PubMed |
| 35693795 | Epigenetics Regulates Antitumor Immunity in Melanoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/35693795 | PubMed |
| 34586646 | DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermis. | EMBO J | 2021 | https://conductscience.org/library/papers/34586646 | PubMed |
| 33980308 | Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences. | BMC Complement Med Ther | 2021 | https://conductscience.org/library/papers/33980308 | PubMed |
| 33669837 | Changes in Apoptotic Pathways in MOLM-13 Cell Lines after Induction of Resistance to Hypomethylating Agents. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33669837 | PubMed |
| 33584800 | Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation. | Front Genet | 2020 | https://conductscience.org/library/papers/33584800 | PubMed |
| 32252665 | The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancers. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32252665 | PubMed |
| 31646020 | Effective demethylation of melanoma cells using terahertz radiation. | Biomed Opt Express | 2019 | https://conductscience.org/library/papers/31646020 | PubMed |
| 31612060 | Diagnostic and prognostic value of the BEX family in lung adenocarcinoma. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31612060 | PubMed |
| 31357729 | DNA Methylation Module Network-Based Prognosis and Molecular Typing of Cancer. | Genes (Basel) | 2019 | https://conductscience.org/library/papers/31357729 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26317460
GET https://conductscience.org/api/papers/v1/26317460/cited_by?page=2